[Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis].

@article{Lin2012ProspectiveCT,
  title={[Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis].},
  author={Hu Lin and Zheng Zhang and Ming Shi and Ruo-nan Xu and Jun-liang Fu and Hua Geng and Yuanyuan Li and Shuang-jie Yu and Li-ming Chen and Sa Lv and Fu-sheng Wang},
  journal={Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology},
  year={2012},
  volume={20 7},
  pages={487-91}
}
OBJECTIVE To evaluate the safety of human umbilical cord derived-mesenchymal stem cell (UC-MSC) transplantation therapy in patients with decompensated liver cirrhosis. METHODS UC-MSCs were transplanted intravenously into patients with decompensated liver cirrhosis. Serum levels of glucose (GLU), total cholesterol (TC), blood urea nitrogen (BUN), alpha fetoprotein (AFP), white blood cells (WBC), and prothrombin activity (PA) were detected at different time points after UC-MSCs transplantation… CONTINUE READING